Anatara Lifesciences Ltd (ANR) — Cash Flow-to-Debt Ratio
Anatara Lifesciences Ltd (ANR) has a Cash Flow-to-Debt Ratio of -2.24x as of June 2025, meaning its operating cash flow of AU$-1.37 Million could theoretically repay -2% of its total liabilities (AU$612.42K) in one year. See Anatara Lifesciences Ltd (ANR) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Anatara Lifesciences Ltd Cash Flow-to-Debt Ratio (2013–2025)
Historical debt coverage capacity for Anatara Lifesciences Ltd across 13 annual periods. Also explore ANR shareholders equity momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Anatara Lifesciences Ltd (2013–2025)
Year-by-year debt coverage analysis for Anatara Lifesciences Ltd. For market capitalisation and broader financial context, see ANR stock market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (AUD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -3.71x | AU$-2.27 Million | AU$612.42K | ▲ +8.7% |
| 2024 | -4.07x | AU$-1.25 Million | AU$306.85K | ▲ +10.9% |
| 2023 | -4.56x | AU$-2.26 Million | AU$494.83K | ▲ +17.6% |
| 2022 | -5.54x | AU$-2.23 Million | AU$403.35K | ▼ -31.1% |
| 2021 | -4.22x | AU$-2.10 Million | AU$496.67K | ▲ +24.5% |
| 2020 | -5.60x | AU$-2.72 Million | AU$486.96K | ▼ -16.7% |
| 2019 | -4.79x | AU$-2.24 Million | AU$466.76K | ▼ -77.1% |
| 2018 | -2.71x | AU$-3.32 Million | AU$1.22 Million | ▲ +72.2% |
| 2017 | -9.74x | AU$-2.88 Million | AU$295.44K | ▼ -1445.1% |
| 2016 | -0.63x | AU$-280.37K | AU$444.62K | ▲ +95.2% |
| 2015 | -13.09x | AU$-1.92 Million | AU$146.98K | ▼ -366.2% |
| 2014 | -2.81x | AU$-639.27K | AU$227.62K | ▼ -459.4% |
| 2013 | -0.50x | AU$-177.22K | AU$352.96K | — |